Los Angeles Capital Management LLC Puma Biotechnology, Inc. Transaction History

Los Angeles Capital Management LLC

$24.2 Billion
Q4 2024

A detailed history of Los Angeles Capital Management LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 285,679 shares of PBYI stock, worth $854,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares

285,679

Previous 245,695 16.27%

Holding current value

$854,180

Previous $626,000 39.14%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$2.42 - $3.39 $96,761 - $135,545	39,984 Added 16.27%	285,679 $871,000
Q3 2024 Nov 04, 2024	BUY	$2.25 - $4.03 $552,813 - $990,150	245,695 New	245,695 $626,000
Q2 2022 Aug 05, 2022	SELL	$1.64 - $3.3 $203,310 - $409,101	-123,970 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$2.13 - $3.24 $13,395 - $20,376	6,289 Added 5.34%	123,970 $357,000
Q4 2021 Feb 03, 2022	SELL	$2.85 - $6.58 $71,991 - $166,210	-25,260 Reduced 17.67%	117,681 $358,000
Q3 2021 Nov 08, 2021	BUY	$6.63 - $9.39 $772,076 - $1.09 Million	116,452 Added 439.62%	142,941 $1 Million
Q2 2021 Aug 05, 2021	BUY	$8.98 - $11.6 $100,845 - $130,268	11,230 Added 73.6%	26,489 $243,000
Q1 2021 May 05, 2021	BUY	$9.38 - $13.63 $143,129 - $207,980	15,259 New	15,259 $148,000
Q3 2020 Nov 02, 2020	SELL	$9.5 - $11.14 $739,252 - $866,870	-77,816 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$7.01 - $13.24 $83,804 - $158,284	11,955 Added 18.15%	77,816 $811,000
Q1 2020 May 04, 2020	BUY	$6.28 - $14.57 $89,615 - $207,913	14,270 Added 27.66%	65,861 $556,000
Q4 2019 Feb 07, 2020	BUY	$6.5 - $10.73 $167,602 - $276,673	25,785 Added 99.92%	51,591 $451,000
Q3 2019 Nov 07, 2019	BUY	$8.75 - $12.85 $225,802 - $331,607	25,806 New	25,806 $278,000
Q2 2019 Jul 29, 2019	SELL	$12.3 - $35.76 $107,182 - $311,612	-8,714 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$20.77 - $42.37 $180,989 - $369,212	8,714 New	8,714 $338,000
Q4 2018 Feb 11, 2019	SELL	$20.07 - $46.7 $267,713 - $622,931	-13,339 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$41.2 - $59.85 $1.53 Million - $2.22 Million	-37,060 Reduced 73.53%	13,339 $612,000
Q2 2018 Jul 31, 2018	BUY	$48.3 - $68.25 $1.26 Million - $1.78 Million	26,120 Added 107.58%	50,399 $2.98 Million
Q1 2018 Apr 27, 2018	BUY	$59.7 - $99.25 $1.45 Million - $2.41 Million	24,279 New	24,279 $1.65 Million
Q4 2017 Feb 05, 2018	SELL	$93.85 - $132.45 $239,692 - $338,277	-2,554 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$72.0 - $119.75 $183,888 - $305,841	2,554	2,554 $306,000

Others Institutions Holding PBYI

# of Institutions

110

Shares Held

28.3M

Call Options Held

27.9K

Put Options Held

3.4K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $136M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Puma Biotechnology, Inc. Transaction History